Friday 13^th April 2018

13:30      Welcome and introduction (D. Betticher, Fribourg)

Prostate Cancer I (D. Zwahlen/S. Gillessen)

13:40      PSMA-PET/CT or PSMA-PET/MRI and when to use it, potential pitfalls (I. Burger, Zürich)

14:00      Discussion

14:10      Oligometastatic prostate cancer: Does it exist and if yes, how is it defined and is it treated? (M. Spahn, Bern)

14:30      Discussion

14:40      Case discussions: Metachronous oligometastatic prostate cancer (M. Spahn, Bern) Panel: M. Spahn, D. Zwahlen, I. Burger, K. Fizazi

15:30      Coffee break

Prostate Cancer II (D. Zwahlen/M. Spahn)

16:00      Castration sensitive prostate cancer (K. Fizazi, Paris)

16:30      Discussion

16:40      Optimal therapy sequence for men with CRPC (A. Templeton, Basel)

17:00      Discussion

17:10      Treatment monitoring in metastatic prostate cancer and when to change treatment (A. Omlin, St. Gallen)

17:30      Discussion

17:40      Adjourn

Saturday 14^th April 2018

Renal Cell Cancer (S. Gillessen)

08:00      Observation or treatment of small masses? (M. Valerio, Lausanne)

08:20      Discussion

08:30      Optimal systemic therapy (V. Grünwald, Hannover)

09:00      Discussion

09:10      Case discussion (V. Grünwald, Hannover)

09:30      Coffee break

Bladder Cancer (M. Spahn)

10:00      Trimodal therapy: For whom and how? (D. Zwahlen, Chur/T. Hermanns, Zürich)

10:30      Discussion

10:40      Immunotherapy or Chemotherapy: Optimal therapy for patients with metastatic disease (S. Schmid, St. Gallen)

11:00      Discussion

11:10      Case discussion (D. Zwahlen, Chur)

12:00      Wrap up (S. Gillessen/M. Spahn/D. Zwahlen)

12:15      End